Research / MAMA / Fundamental state Inspectable configuration
State dimensions Filing 0001493152-22-025874 General Corporate
Capex intensity 6th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.58% · OPTIONAL · VALID
Operating cash generation 65th Own-history percentile · N=17
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
6.90% · OPTIONAL · VALID
Revenue growth 92th Own-history percentile · N=13
Evidence method Yoy · gp.fundamentals.revenue
89.37% · CORE · VALID
Inventory pressure 82th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
18.36% · OPTIONAL · VALID
Gross margin 0th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.gross_margin
11.93% · CORE · VALID
Operating margin 0th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.operating_margin
-3.64% · CORE · VALID
R&D intensity 6th Own-history percentile · N=17
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.18% · OPTIONAL · VALID
SBC intensity 19th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.05% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 35 states Self-history eligible
Jan 31, 2022 8/8 normalized Level 3 Apr 30, 2022 7/7 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 31, 2022 6/6 normalized Level 3 Jan 31, 2023 7/7 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Amended as filed Jul 31, 2023 8/8 normalized Level 3 Oct 31, 2023 8/8 normalized Level 3 Jan 31, 2024 8/8 normalized Level 3 Apr 30, 2024 8/8 normalized Level 3 Jul 31, 2024 8/8 normalized Level 3 Oct 31, 2024 8/8 normalized Level 3 Jan 31, 2025 8/8 normalized Level 3 Apr 30, 2025 8/8 normalized Level 3 Jul 31, 2025 8/8 normalized Level 3 Oct 31, 2025 8/8 normalized Level 3 Jan 31, 2026 9/9 normalized Level 3 Apr 30, 2026 8/8 normalized Level 3 Jul 31, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 0.80%
Current 0.58%
Delta -0.22% Cash Generation Increased
Previous -6.15%
Current 6.90%
Delta 13.05% Growth Decreased
Previous 111.67%
Current 89.37%
Delta -22.30% Inventory Pressure Decreased
Previous 19.10%
Current 18.36%
Delta -0.74% Margin Decreased
Previous 17.68%
Current 11.93%
Delta -5.75% Profitability Decreased
Previous 1.20%
Current -3.64%
Delta -4.83% R And D Intensity Increased
Previous 0.12%
Current 0.18%
Delta 0.06% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.